Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | neuropeptide S receptor 1 | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Equus caballus | Ferritin light chain | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | neuropeptide receptor A26 | Get druggable targets OG5_136011 | All targets in OG5_136011 |
Schistosoma japonicum | IPR000276,Rhodopsin-like GPCR superfamily,domain-containing | Get druggable targets OG5_136011 | All targets in OG5_136011 |
Echinococcus granulosus | neuropeptide s receptor | Get druggable targets OG5_136011 | All targets in OG5_136011 |
Echinococcus granulosus | neuropeptide receptor A26 | Get druggable targets OG5_136011 | All targets in OG5_136011 |
Echinococcus multilocularis | neuropeptide s receptor | Get druggable targets OG5_136011 | All targets in OG5_136011 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Echinococcus granulosus | expressed protein | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 44.4 % |
Echinococcus multilocularis | expressed protein | Ferritin light chain | 175 aa | 146 aa | 30.1 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 43.9 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 142 aa | 29.6 % |
Schistosoma japonicum | Ferritin, putative | Ferritin light chain | 175 aa | 144 aa | 24.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0346 | 0.3031 | 0.6046 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0083 | 0.0582 | 0.0859 |
Loa Loa (eye worm) | hypothetical protein | 0.0747 | 0.6774 | 0.6774 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0083 | 0.0582 | 0.1161 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0083 | 0.0582 | 0.1161 |
Schistosoma mansoni | glutaminase | 0.0546 | 0.4893 | 0.7223 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0083 | 0.0582 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0397 | 0.3507 | 0.3507 |
Loa Loa (eye worm) | TAR-binding protein | 0.0397 | 0.3507 | 0.3507 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0083 | 0.0582 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0397 | 0.3507 | 0.5177 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0346 | 0.3031 | 0.6046 |
Brugia malayi | glutaminase DH11.1 | 0.0546 | 0.4893 | 0.4893 |
Brugia malayi | N-terminal motif family protein | 0.0205 | 0.1715 | 0.1715 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0747 | 0.6774 | 0.6774 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0346 | 0.3031 | 0.3031 |
Loa Loa (eye worm) | hypothetical protein | 0.0163 | 0.1328 | 0.1328 |
Schistosoma mansoni | hypothetical protein | 0.0346 | 0.3031 | 0.4474 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0083 | 0.0582 | 0.0582 |
Echinococcus granulosus | tar DNA binding protein | 0.0397 | 0.3507 | 0.6994 |
Schistosoma mansoni | tar DNA-binding protein | 0.0397 | 0.3507 | 0.5177 |
Loa Loa (eye worm) | hypothetical protein | 0.1093 | 1 | 1 |
Loa Loa (eye worm) | glutaminase 2 | 0.0546 | 0.4893 | 0.4893 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0558 | 0.5014 | 1 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0083 | 0.0582 | 0.1161 |
Loa Loa (eye worm) | hypothetical protein | 0.0205 | 0.1715 | 0.1715 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0083 | 0.0582 | 0.1161 |
Onchocerca volvulus | 0.0163 | 0.1328 | 0.1334 | |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0346 | 0.3031 | 0.3031 |
Echinococcus multilocularis | GPCR, family 2 | 0.0346 | 0.3031 | 0.6046 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0558 | 0.5014 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0397 | 0.3507 | 0.5177 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0083 | 0.0582 | 0.1161 |
Schistosoma mansoni | hypothetical protein | 0.0346 | 0.3031 | 0.4474 |
Loa Loa (eye worm) | pip kinase 2 | 0.0163 | 0.1328 | 0.1328 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.0301 | 0.0301 |
Trichomonas vaginalis | glutaminase, putative | 0.0546 | 0.4893 | 0.5 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0083 | 0.0582 | 1 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.0024 | 0.0028 | 0.0055 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0083 | 0.0582 | 1 |
Brugia malayi | hypothetical protein | 0.0053 | 0.0301 | 0.0301 |
Brugia malayi | Pip kinase protein 2 | 0.0163 | 0.1328 | 0.1328 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.1093 | 1 | 1 |
Schistosoma mansoni | phosphatidylinositol-4-phosphate 5-kinase type II | 0.0163 | 0.1328 | 0.196 |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.1088 | 0.9953 | 0.9953 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0083 | 0.0582 | 0.1161 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0083 | 0.0582 | 1 |
Echinococcus multilocularis | Ataxin 2, N terminal,domain containing protein | 0.0024 | 0.0028 | 0.0055 |
Schistosoma mansoni | hypothetical protein | 0.0346 | 0.3031 | 0.4474 |
Echinococcus granulosus | phosphatidylinositol 5 phosphate 4 kinase type 2 | 0.0163 | 0.1328 | 0.2648 |
Schistosoma mansoni | tar DNA-binding protein | 0.0397 | 0.3507 | 0.5177 |
Brugia malayi | TAR-binding protein | 0.0397 | 0.3507 | 0.3507 |
Brugia malayi | isocitrate dehydrogenase | 0.0083 | 0.0582 | 0.0582 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0346 | 0.3031 | 0.6046 |
Brugia malayi | Pax transcription factor protein 2 | 0.1088 | 0.9953 | 0.9953 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0346 | 0.3031 | 0.6046 |
Loa Loa (eye worm) | glutaminase | 0.0546 | 0.4893 | 0.4893 |
Echinococcus multilocularis | phosphatidylinositol 5 phosphate 4 kinase type 2 | 0.0163 | 0.1328 | 0.2648 |
Onchocerca volvulus | Rap guanine nucleotide exchange factor 1 homolog | 0.0205 | 0.1715 | 0.1723 |
Echinococcus granulosus | GPCR family 2 | 0.0346 | 0.3031 | 0.6046 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0346 | 0.3031 | 0.3031 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0397 | 0.3507 | 0.3507 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0083 | 0.0582 | 1 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0558 | 0.5014 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.1093 | 1 | 1 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0083 | 0.0582 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0346 | 0.3031 | 0.3031 |
Onchocerca volvulus | 0.1088 | 0.9953 | 1 | |
Schistosoma mansoni | tar DNA-binding protein | 0.0397 | 0.3507 | 0.5177 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0083 | 0.0582 | 0.5 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0083 | 0.0582 | 1 |
Brugia malayi | Isocitrate dehydrogenase | 0.0083 | 0.0582 | 0.0582 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0083 | 0.0582 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0346 | 0.3031 | 0.4474 |
Schistosoma mansoni | hypothetical protein | 0.0747 | 0.6774 | 1 |
Brugia malayi | RNA binding protein | 0.0397 | 0.3507 | 0.3507 |
Brugia malayi | hypothetical protein | 0.0034 | 0.0125 | 0.0125 |
Mycobacterium ulcerans | glutaminase | 0.0546 | 0.4893 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0397 | 0.3507 | 0.3507 |
Schistosoma mansoni | phosphatidylinositol-4-phosphate 5-kinase type II | 0.0163 | 0.1328 | 0.196 |
Echinococcus granulosus | neuropeptide s receptor | 0.0558 | 0.5014 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0024 | 0.0028 | 0.0041 |
Echinococcus multilocularis | tar DNA binding protein | 0.0397 | 0.3507 | 0.6994 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.6511 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (binding) | = 3.5481 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | = 6.3096 um | PUBCHEM_BIOASSAY: Confirmation Concentration-Response Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) [Related pubchem assays: 1464, 1461 ] | ChEMBL. | No reference |
Potency (functional) | = 6.3096 um | PUBCHEM_BIOASSAY: Confirmation Concentration-Response Assay for Antagonists of the Neuropeptide S Receptor: Calcium Signal Transduction. (Class of assay: confirmatory) [Related pubchem assays: 1464, 1461 ] | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate. (Class of assay: confirmatory) [Related pubchem assays: 1472, 1467 ] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.